This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 Oct 18;284(15):1922-3; author reply 1923-4.

doi: 10.1001/jama.284.15.1922.

Problems in pharmacoeconomic analyses

PMID: 11035879
DOI: 10.1001/jama.284.15.1922

Comment

Problems in pharmacoeconomic analyses

M Stafford. JAMA. 2000.

. 2000 Oct 18;284(15):1922-3; author reply 1923-4.

doi: 10.1001/jama.284.15.1922.

Author

PMID: 11035879
DOI: 10.1001/jama.284.15.1922

No abstract available

PubMed Disclaimer

Comment on

Problems with the interpretation of pharmacoeconomic analyses: a review of submissions to the Australian Pharmaceutical Benefits Scheme.
Hill SR, Mitchell AS, Henry DA. Hill SR, et al. JAMA. 2000 Apr 26;283(16):2116-21. doi: 10.1001/jama.283.16.2116. JAMA. 2000. PMID: 10791503
Pharmacoeconomic analyses: making them transparent, making them credible.
Rennie D, Luft HS. Rennie D, et al. JAMA. 2000 Apr 26;283(16):2158-60. doi: 10.1001/jama.283.16.2158. JAMA. 2000. PMID: 10791510 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems